If the mountain won't come to Mohammed, then Mohammed must go to the mountain: Decentralisation of hepatitis C care for people who use drugs

In 2016 the World Health Organisation (WHO) set ambitious goals for elimination of Hepatitis C (HCV) by 2030.1 In Europe, HCV prevalence is low in the general population, therefore treatment of high prevalence populations like people who use drugs (PWUD), is crucial to reach the WHO goals. Barriers on patient, provider and system level inhibit successful care delivery in PWUD, leading to low treatment uptake, early loss to follow-up, and a human...